|
|
原发性胆囊癌的研究进展
|
Abstract:
原发性胆囊癌(Primary Gallbladder Carcinoma, PGC)是由多种因素所导致的一种恶性病变，其恶性程度高，一经发现即为进展期或中晚期，且多数预后较差，由于起病隐匿，早期临床表现不明显，因而易被误诊为某些良性疾病。目前以手术为主、辅以放化疗等综合治疗仍是PGC的主要治疗手段，近年来，靶向治疗与免疫治疗成为了治疗PGC研究的热门。
Primary gallbladder carcinoma is a malignant lesion caused by many factors. Its malignant degree is high. Once discovered, it will be progressive or middle and late stage, and most of them have poor prognosis. Due to concealment of onset, the early clinical manifestation is not obvious, so it is easy to be misdiagnosed as some benign diseases. At present, surgery combined with radiotherapy and chemotherapy is still the main treatment for PGC. In recent years, targeted therapy and immuno-therapy have become hot topics in the treatment of PGC.
| [1] | 李连弟, 张思维, 鲁凤珠, 牧人, 孙秀娣, 皇甫小梅, 孙杰, 周有尚, 夏毅, 戴旭东, 饶克勤, 陈育德, 孙爱明, 薛志福. 中国恶性肿瘤死亡谱及分类构成特征研究[J]. 中华肿瘤杂志, 1997, 19(5): 323-328. |
| [2] | Jones, R.S. (1990) Carcinoma of the Gallbladder. Surgical Clinics of North America, 70, 1419-1428.
https://doi.org/10.1016/S0039-6109(16)45292-8 |
| [3] | 窦科峰, 陶开山. 胆囊癌扩大根治的联合脏器切除问题[J]. 中国实用外科杂志, 2005, 25(8): 458-458. |
| [4] | Goetze, T.O. (2015) Gallbladder Carcinoma: Prognostic Factors and Therapeutic Options. World Journal of Gastroenterology, 21, 12211-12217. https://doi.org/10.3748/wjg.v21.i43.12211 |
| [5] | Hundal, R. and Shaffer, E.A. (2014) Gallbladder Cancer: Epidemi-ology and Outcome. Clinical Epidemiology, 6, 99-109.
https://doi.org/10.2147/CLEP.S37357 |
| [6] | Schnelldorfer, T. (2013) Porcelain Gallbladder: A Benign Process or Concern for Malignancy? Journal of Gastrointestinal Surgery, 17, 1161-1168. https://doi.org/10.1007/s11605-013-2170-0 |
| [7] | Hale, M.D., Roberts, K.J., Hodson, J., Scott, N., Sheridan, M. and Toogood, G.J. (2014) Xanthogranulomatous Cholecystitis: A European and Global Perspective. HPB (Oxford), 16, 448-458. https://doi.org/10.1111/hpb.12152 |
| [8] | 刘力玮, 姚贵宾, 白雪松, 等. 胆囊息肉形成相关风险因素的研究进展[J]. 医学研究杂志, 2020, 49(2): 13-15, 19. |
| [9] | 宋彦伟, 程军, 罗威, 等. 胆囊息肉样病变直径对判断息肉性质的价值分析[J]. 实用肝脏病杂志, 2020, 23(1): 130-133. |
| [10] | 徐玉彬, 张培建, 薛峰. 胆囊腺肌症的发病机制与影像学诊断进展[J]. 中华临床医师杂志: 电子版, 2015, 9(11): 134-137. |
| [11] | Aldridge, M.C. (1991) Ad-enomyomatosis of the Gallbladder. A Premalignant Lesion? Surgery, 109, 107-110. |
| [12] | 段建峰, 刘晓晨, 豆发福, 等. 胆囊癌与EB病毒感染的关系初探[J]. 中华肝胆外科杂志, 2014, 20(4): 310-311. |
| [13] | 冉燕翠, 杨翠红, 郑春燕, 等. EB病毒与胆囊癌的关系研究进展[J]. 癌症进展, 2019, 17(11): 1266-1270. |
| [14] | Lax, A.J. and Thomas, W. (2002) How Bacteria Could Cause Cancer: One Step at a Time. Trends in Microbiology, 5, 749-759. https://doi.org/10.1016/S0966-842X(02)02360-0 |
| [15] | 黄俊, 熊杰, 汪宏, 等. 原发性胆囊癌胆囊黏膜和胆汁中螺杆菌相关基因的检测[J]. 中华肝胆外科杂志, 2011, 17(7): 576-579. |
| [16] | 严焕军, 忻畅, 卓奇峰, 等. 黄色肉芽肿性胆囊炎与胆囊癌的特征鉴别分析[J]. 中国中西医结合外科杂志, 2016, 22(5): 485-487. |
| [17] | 刘洪锋, 延学军. 女性胆囊癌发生相关危险因素的分析[J]. 中国现代医生, 2013, 51(7): 12-13. |
| [18] | 姜蔚. 肥胖促进肿瘤发生发展的相关机制研究进展[J]. 中国慢性病预防与控制, 2020, 28(2): 154-158. |
| [19] | Badrick, E., et al. (2014) Diabetes and Cancer: 5 Years into the Recent Controversy. European Journal of Cancer, 50, 2119-2125. https://doi.org/10.1016/j.ejca.2014.04.032 |
| [20] | Muething, L. and Burton, J.R. (2017) Malignancy and Primary Sclerosing Cholangitis: Cholangiocarcinoma, Hepatocellular Carcinoma, and Gallbladder Carcinoma. Springer Interna-tional Publishing, Berlin.
https://doi.org/10.1007/978-3-319-40908-5_2 |
| [21] | Misra, S., Chaturvedi, A. and Misra, N.C. (2006) Gallbladder Cancer. Current Treatment Options in Gastroenterology, 9, 95-106. https://doi.org/10.1007/s11938-006-0028-1 |
| [22] | 李鸿君, 杨文奇. 胆囊癌诊断与手术治疗近况[J]. 中外医学研究, 2010, 8(8): 28-30. |
| [23] | 张兰, 王培军. B超、CT和MRCP对原发性胆囊癌的诊断价值[J]. 同济大学学报: 医学版, 2010, 31(6): 59-63. |
| [24] | 夏泽亮, 刘会春. 胆囊癌的诊断与手术治疗现状[J]. 肝胆外科杂志, 2012, 20(6): 476-478. |
| [25] | Wen, Z., Si, A., Yang, J., et al. (2017) Elevation of CA19-9 and CEA Is Associated with a Poor Progno-sis in Patients with Resectable Gallbladder Carcinoma. HPB, 19, 951-956. https://doi.org/10.1016/j.hpb.2017.06.011 |
| [26] | Wernberg, J.A. and Lucarelli, D.D. (2014) Gallbladder Cancer. Surgical Clinics of North America, 94, 343-360.
https://doi.org/10.1016/j.suc.2014.01.009 |
| [27] | Benson, A.B., D’Angelica, M.I., Abrams, T.A., et al. (2014) Hepatobiliary Cancers, Version 2. Journal of the National Comprehensive Cancer Network: JNCCN, 12, 1152-1182. https://doi.org/10.6004/jnccn.2014.0112 |
| [28] | Creasy, J.M., Goldman, D.A., Dudeja, V., et al. (2017) Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. Journal of the American College of Surgeons, 224, 906-916. https://doi.org/10.1016/j.jamcollsurg.2016.12.058 |
| [29] | Fong, Y., Wagman, L., Gonen, M., et al. (2006) Evi-dence-Based Gallbladder Cancer Staging. Annals of Surgery, 243, 771-774. https://doi.org/10.1097/01.sla.0000219737.81943.4e |
| [30] | Birnbaum, D.J., et al. (2015) Lymph Node Metastases in Patients Undergoing Surgery for a Gallbladder Cancer. Extension of the Lymph Node Dissection and Prognostic Value of the Lymph Node Ratio. Annals of Surgical Oncology, 22, 811-818. https://doi.org/10.1245/s10434-014-4044-4 |
| [31] | Hidetoshi, E., Osamu, I., Hiroaki, O., et al. (2005) Surgical Sig-nificance of Superficial Cancer Spread in Early Gallbladder Cancer. Japanese Journal of Clinical Oncology, 35, 134-138. https://doi.org/10.1093/jjco/hyi042 |
| [32] | Qiu, Y., Liu, C., Bin, Y.I., et al. (2010) Long-Term Results of Surgical Treatment in 181 Cases of Advanced Stage Gallbladder Carcinoma. |
| [33] | 洪德飞, 彭淑牖. 胆囊癌合理根治术的决策依据和疗效评价[J]. 外科理论与实践, 2011, 16(4): 336-339. |
| [34] | Hari, D.M., Howard, J.H., Leung, A.M., et al. (2012) A 21-Year Analysis of Stage I Gallbladder Carcinoma: Is Cholecystectomy Alone Adequate? HPB, 15, 40-48. https://doi.org/10.1111/j.1477-2574.2012.00559.x |
| [35] | Horgan,A.M., Amir, E., et al. (2012) Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30, 1934-1940. https://doi.org/10.1200/JCO.2011.40.5381 |
| [36] | Edeline, J., et al. (2019) Gemcitabine and Oxaliplatin Chemothera-py or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 37, 658-667. |
| [37] | 徐晗, 孙强, 殷保兵. 胆囊癌的靶向治疗进展[J]. 中华肝脏外科手术学电子杂志, 2018, 7(3): 244-247. |
